CLOV earnings date and last-quarter result: last quarter beat, P/E -41.96. Updated 2026-07-23.
Clover Health Investments (CLOV) Research Hub
Clover Health Investments (CLOV) trades on NASDAQ, US in the Healthcare (Medical - Healthcare Plans) sector. As of 2026-10-26, shares last closed at 4.56 USD (-0.87%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -41.96, market cap 2.47B. This hub links to the full technical, earnings and options research available for CLOV.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Healthcare Plans) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 4.56 USD (-0.87%) |
| 52-week range | 4.04 USD – 5.51 USD |
| Trend regime | Range |
| 14-day RSI | 48.4 (Neutral) |
| Trailing P/E | -41.96 |
| Market cap | 2.47B |
| Dividend yield | 0.00% |
Available research for CLOV
Covered Call on CLOV: how it works, illustrative setup around the real 4.56 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CLOV: how it works, illustrative setup around the real 4.56 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CLOV: how it works, illustrative setup around the real 4.56 USD price, max profit/loss, breakeven and when to use it. Educational.
CLOV technical analysis: range, last 4.56 USD, RSI 48.4, 52w range 4.04 USD–5.51 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is CLOV in?
Clover Health Investments (CLOV) is classified under Healthcare (Medical - Healthcare Plans), listed on NASDAQ, US.
Is CLOV in an uptrend or downtrend?
As of 2026-10-26, CLOV is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CLOV's trailing P/E ratio?
CLOV's trailing P/E is -41.96, with a market cap of 2.47B. See the earnings research page for full valuation detail.